GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Liaoning Chengda Biotechnology Co Ltd (SHSE:688739) » Definitions » EBITDA Margin %

Liaoning Chengda Biotechnology Co (SHSE:688739) EBITDA Margin % : 22.41% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Liaoning Chengda Biotechnology Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Liaoning Chengda Biotechnology Co's EBITDA for the three months ended in Mar. 2025 was ¥80 Mil. Liaoning Chengda Biotechnology Co's Revenue for the three months ended in Mar. 2025 was ¥358 Mil. Therefore, Liaoning Chengda Biotechnology Co's EBITDA margin for the quarter that ended in Mar. 2025 was 22.41%.


Liaoning Chengda Biotechnology Co EBITDA Margin % Historical Data

The historical data trend for Liaoning Chengda Biotechnology Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Liaoning Chengda Biotechnology Co EBITDA Margin % Chart

Liaoning Chengda Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.90 55.01 52.93 40.17 34.41

Liaoning Chengda Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.67 31.86 31.57 -0.32 22.41

Competitive Comparison of Liaoning Chengda Biotechnology Co's EBITDA Margin %

For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Liaoning Chengda Biotechnology Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Liaoning Chengda Biotechnology Co's EBITDA Margin % falls into.


;
;

Liaoning Chengda Biotechnology Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Liaoning Chengda Biotechnology Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=576.785/1676.241
=34.41 %

Liaoning Chengda Biotechnology Co's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=80.321/358.396
=22.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Liaoning Chengda Biotechnology Co  (SHSE:688739) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Liaoning Chengda Biotechnology Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Liaoning Chengda Biotechnology Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Liaoning Chengda Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Xinfang Street, Hunnan New District, Liaoning Province, Shenyang, CHN, 110179
Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.
Executives
Li Ning Director
Cui Jian Wei senior management
Chen Xin senior management
Zhang Shu Min Director
Zhou Li Bao senior management
Yuan De Ming senior management
Gao Jun Director
Yang Xu Director

Liaoning Chengda Biotechnology Co Headlines

No Headlines